Syneos Health Inc.

05/21/2019 | Press release | Distributed by Public on 05/21/2019 15:05

Syneos Health to Present at Upcoming Investor Conferences

MORRISVILLE, N.C., May 21, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that the Company is scheduled to present at two upcoming investor conferences:

  • Chief Executive Officer Alistair Macdonald is scheduled to present at the Jefferies 2019 Healthcare Conference in New York, NY, on Wednesday, June 5, 2019, at 10:30 a.m. ET.
  • Chief Financial Officer Jason Meggs is scheduled to present at the Goldman Sachs 40th Annual Global Healthcare Conference in Rancho Palos Verdes, CA, on Wednesday, June 12, 2019, at 9:20 a.m. PT.

A live webcast of both events, along with links to the presentation materials and archived audio replays of the presentations, will be available on the Company's Investor Relations website at

About Syneos Health

Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies - INC Research and inVentiv Health - we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit


Investor Relations:Ronnie Speight
Senior Vice President, Investor Relations
+1 919 745 2745
[email protected]

Press/Media:Danielle DeForge
Executive Director, External Communications
+1 202 210 5992
[email protected]

Source: Syneos Health, Inc.